> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Biosimilar User Fee Reauthorization Meeting
- URL: https://www.fdaweb.com/biosimilar-user-fee-reauthorization-meeting/
- Published: 2020-10-29T12:00:00.000Z
- Updated: 2026-09-14T16:34:33.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147981

*Federal Register* notice: FDA announces an 11/19 virtual public meeting on reauthorizing the Biosimilar User Fee Act (BsUFA) for fiscal years 2023 through 2027\. BsUFA authorizes FDA to collect user fees to support the review process for biosimilar biological products. The current legislative authority for BsUFA expires 9/20/2022\. To view the notice, click [here](https://public-inspection.federalregister.gov/2020-24028.pdf?ref=fdaweb.com).